Updated Jul 16, 2026
Reynoso Jamie L. has filed 5 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $240K.
Jamie L. Reynoso is the CEO of Clover Health Investments Corp, a healthcare technology company focused on Medicare Advantage. Under his leadership, the company aims to enhance chronic disease management through its innovative software platform, Clover Assistant.
| Role | CEO, Medicare Advantage |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale | 2.4K | $4.68 | $11K |
| 2026-07-06 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale | 6.2K | $5.26 | $33K |
| 2026-06-18 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale | 2.4K | $4.78 | $11K |
| 2026-06-16 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale | 6.3K | $4.61 | $29K |
| 2026-06-11 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale | 7.3K | $4.91 | $36K |
| 2026-04-16 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 12.7K | $2.04 | $26K |
| 2026-04-07 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 6.2K | $1.72 | $11K |
| 2026-04-03 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | A — Grant or award | 159.4K | $0.00 | |
| 2026-03-18 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale [10b5-1] | 5.8K | $1.91 | $11K |
| 2026-03-17 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 6.2K | $1.98 | $12K |
| 2026-03-17 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 8.9K | $1.98 | $18K |
| 2026-01-20 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale [10b5-1] | 4.6K | $2.58 | $12K |
| 2026-01-20 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture [10b5-1] | 14.7K | $2.81 | $41K |
| 2025-12-16 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 8.7K | $2.70 | $23K |
| 2025-12-16 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 12.6K | $2.70 | $34K |
| 2025-10-15 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 71.4K | $2.80 | $200K |
| 2025-10-03 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale | 2.0K | $2.65 | $5K |
| 2025-10-03 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 8.7K | $2.59 | $23K |
| 2025-09-17 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | S — Open-market sale | 4.9K | $3.09 | $15K |
| 2025-09-14 | CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | F — Tax withholding / forfeiture | 8.7K | $3.14 | $27K |
Jamie L. Reynoso is the CEO of Clover Health Investments Corp, a healthcare technology company focused on Medicare Advantage. Under his leadership, the company aims to enhance chronic disease management through its innovative software platform, Clover Assistant.…
5 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 12 open-market sales ($240K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Reynoso Jamie L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.